Transgenic mice expressing oncogenic K-Ras in their liver develop hepatocellular carcinoma and metastasis that is preceded by EMT enforced by coordinate signaling between K-Ras/MAP-kinase and TGFβ [65]. The gene discussed is KRAS; the disease is hepatocellular carcinoma.